YAP1 and pancreatic neoplasm: Moreover, we evaluated the effects of irbesartan in the KPC mouse model and found that irbesartan significantly reduced c-Jun expression, Hippo/YAP1 activity, and the expression levels of stemness and iron metabolism genes in pancreatic tumors in the KPC mouse model (Fig. S15).